@amtdutt @VanitaNoronha @TataMemorial @onecelldx @ESMO_Open @LungConnectIN @DrVijayPatil11 @drakhilkapoor1 @SewantiLimaye @ACTREC_TMC @AlertOnco @oncodaily @VivekSubbiah @Dr_R_Kurzrock Congratulations to the team!
English
Bhasker Dharavath
54 posts
Bhasker Dharavath retweetledi
Why do some lung cancer patients relapse early on targeted therapy? Our study with Drs. K Prabhash, @VanitaNoronha & team from @TataMemorial in collab with Drs. J Khandare, G Shafi, & team from @onecelldx published in ESMO Open (@ESMO_Open) sheds insights. sciencedirect.com/science/articl…
English
@MadhuraKetkar @NeuroOnc @DuttShilpee @desaisanket12 @pranavrana1999 @amtdutt @RahulThorat9769 Congrats Madhura!
Català
Thrilled to share this publication in @NeuroOnc culminated from my Ph.D. work! Eternally grateful to @DuttShilpee for her guidance and to all the contributors @desaisanket12 @pranavrana1999 @amtdutt @RahulThorat9769 Dr.SridharEpari. academic.oup.com/neuro-oncology…
English
@DuttShilpee @MadhuraKetkar @NeuroOnc @DBTIndia @serbonline @ACTREC_TMC @CRI_ACTREC Congratulations Madhura, Shilpee Ma'am, and the team! Nice work!!
English
Congratulations to the brilliant PhD student, @MadhuraKetkar for this excellent study identifying molecular switch for TIS reversal in GBM. Paper's now online @NeuroOnc. Thank you co-authors, @DBTIndia, @serbonline, @ACTREC_TMC, @CRI_ACTREC for support
academic.oup.com/neuro-oncology…
English
@BIDMC_Medicine @harvardmed @CRI_ACTREC @HydUniv @Jnv_India Thank you so much! Immensely glad to be a part of BI!!
English
@dbhaskarjnv @harvardmed @CRI_ACTREC @HydUniv @Jnv_India Welcome to Boston, @dbhaskarjnv!! Excited to have you with us! 🎉🔬
English
Happy to share that I've joined @BIDMC_Medicine and @harvardmed Boston, MA as a Postdoctoral Research Fellow! Ready to dive deeper into cancer research and collaborate with amazing minds! Thank you all for the support @CRI_ACTREC @HydUniv @Jnv_India #HarvardPostdoc #Research
English
@SushmitaVarhadi @BIDMC_Medicine @harvardmed @CRI_ACTREC @HydUniv @Jnv_India Thanks you so much @SushmitaVarhadi !!
English
@dbhaskarjnv @BIDMC_Medicine @harvardmed @CRI_ACTREC @HydUniv @Jnv_India Congratulations Bhaskar and I wish you all the best for your new exciting journey!
English
@ankita_pal11 @amtdutt @Nature_NPJ Thank you so much @ankita_pal11 for your kind words and wishes, and for the immense contribution in this study.
English
This indeed is an example of sheer hardwork to conclude this impactful study in a beautiful way. Special mention and congratulations to Dr. @dbhaskarjnv and @amtdutt Sir to shape the study such that it has found its place in @Nature_NPJ precision oncology. Cheers to the team!
Amit Dutt@amtdutt
UBE3C-LRP5, novel oncogenic fusion-transcript in oral cancer @ 5.3% in Indian & 1.2% TCGA patients. Kudos to @dbhaskarjnv & Ashwin Butle in collab with Dr. Sudhir Nair! Pyrv' pamoate, an FDA approved dewormer, targets this fusion. A potential game-changer! nature.com/articles/s4169…
English
@desaisanket12 @NAR_Cancer_EIC @amtdutt @CRI_ACTREC @ACTREC_TMC Many many congratulations @desaisanket12
English
The first project you do in your PhD is always dear to you the most! It's out in NAR Cancer (@NAR_Cancer_EIC)!
A computational method to identify cancer driving mutations using protein structure and sequence conservation.
@amtdutt @CRI_ACTREC @ACTREC_TMC
Amit Dutt@amtdutt
Pleased to share the dev' of DOME by @desaisanket12 and team! Thanks @NAR_Cancer_EIC & @ACTREC_TMC. This powerful comput'l framework identifies potential driver mutations, advanc'g personalized cancer therapy with emphas' on VUS ! @CRI_ACTREC @UnivofDelhi academic.oup.com/narcancer/arti…
English
@amtdutt @ACTREC_TMC @CRI_ACTREC @DBTIndia @India_Alliance @DAEIndia @UnivofDelhi @the_hindu @biopatrika @desaisanket12 @Dr_R_Kurzrock @VanitaNoronha @ISMPOofficial @TataMemorial @DuttShilpee Thank you @amtdutt Sir and everyone for the wishes! Congratulations to both the teams!!
English
The Tail & Tango of Cancer genome-- we developed a tool “DOME” to tame the tail of rare mutations; in another study, we describe the first chromosomal tango “Chr 11/5 fusion” in oral cancer genome. Thanks to @ACTREC_TMC,@CRI_ACTREC,@DBTIndia,@India_Alliance,@DAEIndia,@UnivofDelhi
English
Thank you @the_hindu and @IndianExpress for featuring the studies! Congratulations to @amtdutt Sir, Team Fusion and Team DOME!!
Amit Dutt@amtdutt
The Tail & Tango of Cancer genome-- we developed a tool “DOME” to tame the tail of rare mutations; in another study, we describe the first chromosomal tango “Chr 11/5 fusion” in oral cancer genome. Thanks to @ACTREC_TMC,@CRI_ACTREC,@DBTIndia,@India_Alliance,@DAEIndia,@UnivofDelhi
English
@Neelima__Yadav @amtdutt Thank you so much for the wishes!! 🙏🙏
English
@dbhaskarjnv @amtdutt Best of luck for new ventures in Boston! Congratulations again best batch-labmate!
English
Delighted to share the findings from my PhD thesis, highlighting the role of a novel oncogenic fusion transcript, UBE3C-LRP5, in oral cancer. Pyrvinium pamoate targets the fusion-positive tumors! Highly grateful to @amtdutt for the support and encouragement. Kudos to the team!!
Amit Dutt@amtdutt
UBE3C-LRP5, novel oncogenic fusion-transcript in oral cancer @ 5.3% in Indian & 1.2% TCGA patients. Kudos to @dbhaskarjnv & Ashwin Butle in collab with Dr. Sudhir Nair! Pyrv' pamoate, an FDA approved dewormer, targets this fusion. A potential game-changer! nature.com/articles/s4169…
English
@Neelima__Yadav @amtdutt Thank you so much @Neelima__Yadav for your kind words and wishes! I am highly grateful to you for all the help, support and encouragement throughout my PhD journey!! Wish you good luck for all your future endeavours!
English
@dbhaskarjnv @amtdutt Bhasker, hats off to you! Your hardwork proved again! Happy to witness the culmination of years spent discovering various UBE3C-LRP5 variants, meticulously validating and characterizing its significance in the Wnt/beta-catenin pathway. Yet another proud milestone in your career!
English
English
Impactful work! Big congratulations to @amtdutt Sir, @dbhaskarjnv and entire Team Fusion! Intricate twists and turns of fusion transcript turned out so meaningful and promising for treating head and neck cancer patients. Congratulations and Celebrations! Dutt Lab rocks!
Amit Dutt@amtdutt
UBE3C-LRP5, novel oncogenic fusion-transcript in oral cancer @ 5.3% in Indian & 1.2% TCGA patients. Kudos to @dbhaskarjnv & Ashwin Butle in collab with Dr. Sudhir Nair! Pyrv' pamoate, an FDA approved dewormer, targets this fusion. A potential game-changer! nature.com/articles/s4169…
English
@amtdutt @desaisanket12 @NAR_Cancer_EIC @ACTREC_TMC @CRI_ACTREC @UnivofDelhi Wonderful work! Many many congratulations Amit Sir, Sanket and team!!
English
Pleased to share the dev' of DOME by @desaisanket12 and team! Thanks @NAR_Cancer_EIC & @ACTREC_TMC. This powerful comput'l framework identifies potential driver mutations, advanc'g personalized cancer therapy with emphas' on VUS ! @CRI_ACTREC @UnivofDelhi academic.oup.com/narcancer/arti…
English
@desaisanket12 @amtdutt @CRI_ACTREC Thank you for the immense help in the analysis and for the intellectual inputs and discussions. Always a pleasure working with you. Hope our paths cross again in future.
English
Personally, this has been the most technically challenging study I've had the privilege to observe closely. Super interesting work by @dbhaskarjnv at @amtdutt lab (@CRI_ACTREC), with high translation potential. Kudos!!
Amit Dutt@amtdutt
UBE3C-LRP5, novel oncogenic fusion-transcript in oral cancer @ 5.3% in Indian & 1.2% TCGA patients. Kudos to @dbhaskarjnv & Ashwin Butle in collab with Dr. Sudhir Nair! Pyrv' pamoate, an FDA approved dewormer, targets this fusion. A potential game-changer! nature.com/articles/s4169…
English
English
@amtdutt Thank you so much, Sir, for your kind words. It was possible only because of your support, encouragement, and motivation.
English
@dbhaskarjnv So delighted to see your hard work culminate in this significant publication, Bhasker! Paving the way for targeted therapies in oral cancer. A true testament to your creative thinking and dedication!
English
@amtdutt @dbhaskarjnv @headandneckcan @DrVijayPatil11 @oralcancerfnd @desaisanket12 @docdcruz @Dr_R_Kurzrock @UnivofDelhi @ACTREC_TMC @CRI_ACTREC @VanitaNoronha Congratulations Amit, Bhaskar and team! Fantastic work!!
English
UBE3C-LRP5, novel oncogenic fusion-transcript in oral cancer @ 5.3% in Indian & 1.2% TCGA patients. Kudos to @dbhaskarjnv & Ashwin Butle in collab with Dr. Sudhir Nair! Pyrv' pamoate, an FDA approved dewormer, targets this fusion. A potential game-changer! nature.com/articles/s4169…
English
@subir_biswas88 @amtdutt @headandneckcan @DrVijayPatil11 @oralcancerfnd @desaisanket12 @docdcruz @Dr_R_Kurzrock @UnivofDelhi @ACTREC_TMC @CRI_ACTREC @VanitaNoronha Thank you, Subir Sir.
English
@amtdutt @dbhaskarjnv @headandneckcan @DrVijayPatil11 @oralcancerfnd @desaisanket12 @docdcruz @Dr_R_Kurzrock @UnivofDelhi @ACTREC_TMC @CRI_ACTREC @VanitaNoronha Congratulations to Amit, Bhaskar and the entire team for this wonderful paper.
English